Erector Spinae Regional Anesthesia for Pain Control

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

EARLY_PHASE1

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-15

Study Completion Date

2025-02-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Interventional study to use erector spinae plane block (ESPB) on diagnoses of posterior or lateral rib fractures, vertebral fractures, pancreatitis, pancreatic cancer, renal colic, and back pain for multimodal pain therapy to determine its assistance with pain relief as well as the patient's use of opiates after block completion

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Erector Spinae Plane Block Versus Conventional Analgesia in Complex Spine Surgery

NCT04156581

Opioid Use Pain, Postoperative

COMPLETED PHASE4

ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy

NCT05024344

Nephrolithotomy, Percutaneous

RECRUITING NA

Erector Spine Block for Back Surgery

NCT03214536

Spine Disease Regional Anaesthesia

COMPLETED NA

Erector Spinae Plane Block For Analgesia Following Video-Assisted Thoracoscopic Surgery

NCT03860480

Thoracic Surgery, Video-Assisted

COMPLETED NA

Effects of Continuous ESP Catheters on Recovery, Pain and Opioid Consumption After Multilevel Spine Surgery

NCT05494125

Post Operative Pain Spine Surgery

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with the listed diagnoses will be offered and then consented for an ESPB under ultrasound guidance. They will rate their pain before and 30 minutes after the procedure using the ordinal categorical data on a numeric pain scale. Total patient opiate use will be gathered up to 8 hours after block completion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Single group open label assignment

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erector Spinae Plane Block (ESP) administration

Patients with the listed diagnoses will be offered and then consented for an ESPB under ultrasound guidance.

Group Type EXPERIMENTAL

Bupivacaine Injection

Intervention Type DRUG

Bucivacaine will be administered intramuscularly according to package insert directions after first numbing the area with lidocaine subcutaneously

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupivacaine Injection

Bucivacaine will be administered intramuscularly according to package insert directions after first numbing the area with lidocaine subcutaneously

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Bupivacaine Hydrochloride Injection

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Posterior/lateral rib or vertebral fractures
* Pancreatitis or pancreatic cancer
* Renal colic
* Back pain

Exclusion Criteria

* Unstable vitals
* Infection or open wound over insertion site
* Prior allergic reaction to local anesthetic
* Pregnant females
* Patients \<18 years old
* Altered mentation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No